Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:RVV) (USA: RVVTF), announces that it has filed a Form 51-102F4 Business Acquisition Report (BAR) pursuant to National Instrument 51-102 Continuous Disclosure Obligations in connection with its acquisition of Psilocin Pharma Corp. on March 5, 2020. The BAR has been filed as a result of a review conducted by staff at the Ontario Securities Commission in connection with the Company’s recently filed preliminary short form prospectus dated January 26, 2021.
For more information, please contact:
Michael Frank
Chief Executive Officer
Revive Therapeutics Ltd.
Tel: 1 888 901 0036
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Website: www.revivethera.com
| Last Trade: | US$0.006 |
| Daily Change: | -0.0002 -3.23 |
| Daily Volume: | 100,937 |
| Market Cap: | US$2.510M |
November 12, 2024 October 31, 2024 September 18, 2024 August 28, 2024 July 02, 2024 | |
Northstar Clean Technologies is a cleantech company focused on the sustainable recovery and reprocessing of asphalt shingles. Northstar’s mission is to be the leader in the recovery and reprocessing of asphalt shingles in North America...
CLICK TO LEARN MORE
Hillcrest Energy Technologies is a clean technology company developing high value, high performance power conversion technologies and digital control systems for next-generation powertrains and grid-connected renewable...
CLICK TO LEARN MORE